Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedJan 21, 2025
DataAggregated Company Financials
Companies9
  • 7D1.8%
  • 3M-10.2%
  • 1Y-17.3%
  • YTD7.3%

In the last week, the Life Sciences industry is up 1.5%, with EirGenix up 3.9%. Meanwhile, DuoGenic StemCells actually underperformed within the industry, shrinking 18% in the last week. In contrast, the industry has lost 16% in the last 12 months. Earnings are forecast to grow by 40% annually.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Jan 2025NT$36.9bNT$2.6b-NT$854,432,000.0023.3x-43.2x14.4x
Thu, 19 Dec 2024NT$35.4bNT$2.6b-NT$854,432,000.0024.9x-41.4x13.8x
Sat, 16 Nov 2024NT$40.7bNT$2.5b-NT$856,799,000.0024x-47.5x16x
Mon, 14 Oct 2024NT$40.7bNT$2.3b-NT$836,610,000.0022.1x-48.7x17.9x
Wed, 11 Sep 2024NT$40.2bNT$2.3b-NT$836,610,000.0021.2x-48.1x17.7x
Fri, 09 Aug 2024NT$39.3bNT$2.1b-NT$797,765,000.0030.7x-49.2x18.4x
Sun, 07 Jul 2024NT$44.7bNT$2.1b-NT$797,765,000.0034.5x-56.1x21x
Tue, 04 Jun 2024NT$41.0bNT$2.1b-NT$797,765,000.0033.1x-51.4x19.2x
Thu, 02 May 2024NT$40.0bNT$2.1b-NT$914,899,000.0032.2x-43.7x18.8x
Sat, 30 Mar 2024NT$40.3bNT$2.1b-NT$903,875,000.0031.7x-44.6x19.1x
Mon, 26 Feb 2024NT$43.6bNT$2.1b-NT$610,218,000.0033x-71.5x21x
Wed, 24 Jan 2024NT$46.7bNT$2.1b-NT$610,218,000.0033x-76.5x22.5x
Fri, 22 Dec 2023NT$47.7bNT$2.1b-NT$610,218,000.0034.1x-78.1x23x
Sun, 19 Nov 2023NT$48.9bNT$2.1b-NT$609,632,000.0031x-80.1x23.5x
Tue, 17 Oct 2023NT$47.7bNT$2.2b-NT$497,769,000.0031.1x-95.8x21.4x
Thu, 14 Sep 2023NT$43.6bNT$2.2b-NT$497,769,000.0031x-87.7x19.6x
Sat, 12 Aug 2023NT$43.9bNT$2.3b-NT$479,239,000.0042.6x-91.7x19.4x
Mon, 10 Jul 2023NT$48.8bNT$2.5b-NT$274,767,000.0042.7x-177.6x19.9x
Wed, 07 Jun 2023NT$49.6bNT$2.5b-NT$274,767,000.0043.1x-180.4x20.2x
Fri, 05 May 2023NT$51.6bNT$2.7b-NT$29,017,000.0024.4x-1778x19.4x
Sun, 02 Apr 2023NT$49.9bNT$2.7b-NT$29,761,000.0024.3x-1676.3x18.8x
Tue, 28 Feb 2023NT$50.3bNT$2.7bNT$85.3m19.7x589.9x18.8x
Thu, 26 Jan 2023NT$45.3bNT$2.7bNT$85.3m19.1x531.4x16.9x
Sat, 24 Dec 2022NT$50.6bNT$2.7bNT$139.5m18.9x362.6x18.9x
Mon, 21 Nov 2022NT$51.1bNT$2.7bNT$139.5m18.4x366.4x19.1x
Wed, 19 Oct 2022NT$45.6bNT$3.0bNT$482.8m23.1x94.4x15.2x
Fri, 16 Sep 2022NT$49.7bNT$3.0bNT$482.8m27.6x103x16.6x
Sun, 14 Aug 2022NT$40.9bNT$3.0bNT$337.4m37.8x121.1x13.4x
Tue, 12 Jul 2022NT$39.1bNT$3.1bNT$325.1m37.6x120.1x12.7x
Thu, 09 Jun 2022NT$39.4bNT$3.1bNT$325.1m36.3x121.1x12.8x
Sat, 07 May 2022NT$32.7bNT$2.9bNT$80.8m27.8x405x11.2x
Mon, 04 Apr 2022NT$33.3bNT$3.2bNT$164.4m28x202.2x10.4x
Wed, 02 Mar 2022NT$35.9bNT$3.0b-NT$120,147,000.0035.7x-298.9x11.8x
Fri, 28 Jan 2022NT$35.8bNT$3.0b-NT$120,147,000.0034.3x-298.1x11.8x
Price to Earnings Ratio

-298.1x


Total Market Cap: NT$35.8bTotal Earnings: -NT$120,147,000.00Total Revenue: NT$3.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Life Sciences Industry Price to Earnings3Y Average -73.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 17.5x is higher than the industry's current PS ratio of 14.5x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
  • Revenues have also declined 5.6% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market3.46%
Healthcare0.0098%
Life Sciences1.85%
Clinical Research and Equipment1.85%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6662 BioLASCO TaiwanNT$34.001.5%
+NT$12.8m		-1.2%PE20.5x
6848 RBC BioscienceNT$19.101.3%
+NT$3.2m		25.2%PE14.4x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6662

NT$34.00

BioLASCO Taiwan

7D

1.5%

1Y

-1.2%

6589

NT$76.40

EirGenix

7D

-2.4%

1Y

-22.2%

6986

NT$70.60

HeXun Biosciences

7D

-1.0%

1Y

12.6%

6848

NT$19.10

RBC Bioscience

7D

1.3%

1Y

25.2%

7607

NT$18.20

DuoGenic StemCells

7D

-18.0%

1Y

-52.0%

6939

NT$27.60

TFBS Bioscience

7D

-0.4%

1Y

-38.7%

4133

NT$29.50

Abnova (Taiwan)

7D

-3.6%

1Y

-13.5%

We Think You Should Be Aware Of Some Concerning Factors In Abnova (Taiwan)'s (TWSE:4133) Earnings

Nov 21
We Think You Should Be Aware Of Some Concerning Factors In Abnova (Taiwan)'s (TWSE:4133) Earnings

6891

NT$19.55

Locus Cell

7D

-1.8%

1Y

-34.8%